Wellbutrin Tablet, Extended Release
Product Images NDC 0187-0730

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Wellbutrin (NDC 0187-0730). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150carton

WELLBUTRIN XL 150 mg extended-release tablets packaging label by Bausch Health US LLC. The label highlights a 30-tablet count with dosage strength 150 mg. It includes NDC 0187-0730-30, dosage form as oral extended-release tablets, and uses blue, white, yellow, and orange colors in its design. The label also notes it as a prescription drug with warnings and federal labeling requirements.*

FDA Label Image

300carton

Label for WELLBUTRIN XL 300 mg extended-release tablets, supplied in a package of 30 tablets. The product contains bupropion hydrochloride and is indicated for oral administration. The label includes usage warnings, directions to consult with healthcare providers, and is labeled as Rx only. The manufacturer is Bausch Health US LLC. The NDC code is 0187-0731-30.*

FDA Label Image

Wellbutrin Chemical Structure (Image 01)

Chemical structure of bupropion hydrochloride showing a chlorophenyl ring connected to a ketone and a tert-butylamino group, along with HCl indicated separately.*

FDA Label Image

Image 02

Drug facts panel listing potential side effects or symptoms related to WELLBUTRIN XL (bupropion hydrochloride) extended-release tablets. The text includes symptoms such as urge to smoke, depressed mood, trouble sleeping, irritability, frustration, anger, anxious feelings, difficulty concentrating, restlessness, decreased heart rate, increased appetite, and weight gain.*

FDA Label Image

Image 03

Drug Facts panel for WELLBUTRIN XL (bupropion hydrochloride) extended-release tablets, listing possible side effects such as trouble sleeping, stuffy nose, dry mouth, dizziness, feeling anxious, nausea, constipation, and joint aches. The panel provides safety information related to the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.